Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives

Relapsed/refractory multiple myeloma remains a challenging disease necessitating the development of more effective treatment options. In the past decade, myeloma therapies have made significant advancements with the introduction of new treatment modalities. One of the new major targets for these nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrivastava, Trilok, Van Rhee, Frits, Al Hadidi, Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290473/
https://www.ncbi.nlm.nih.gov/pubmed/37359353
http://dx.doi.org/10.2147/OTT.S370880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290473/
https://www.ncbi.nlm.nih.gov/pubmed/37359353
http://dx.doi.org/10.2147/OTT.S370880

Ejemplares similares